Bifogade filer
Announcement 270 - Preliminary revenue 2023-24_UK
Kurs
+15,06%
Likviditet
144 MDKK
Kalender
| Tid* | ||
| 2025-10-09 | N/A | Årsstämma |
| 2025-09-11 | 08:00 | Bokslutskommuniké 2025 |
| 2025-02-05 | 17:00 | Kvartalsrapport 2025-Q2 |
| 2024-10-11 | - | X-dag ordinarie utdelning CHEMM 4.00 DKK |
| 2024-10-10 | - | Årsstämma |
| 2024-09-11 | - | Bokslutskommuniké 2024 |
| 2024-02-05 | - | Kvartalsrapport 2024-Q2 |
| 2023-10-13 | - | X-dag ordinarie utdelning CHEMM 6.00 DKK |
| 2023-10-12 | - | Årsstämma |
| 2023-09-14 | - | Bokslutskommuniké 2023 |
| 2023-05-09 | - | 15-10 2023-Q3 |
| 2023-02-09 | - | Kvartalsrapport 2023-Q2 |
| 2022-10-14 | - | X-dag ordinarie utdelning CHEMM 0.00 DKK |
| 2022-10-13 | - | Årsstämma |
| 2022-09-15 | - | Bokslutskommuniké 2022 |
| 2022-02-08 | - | Kvartalsrapport 2022-Q2 |
| 2021-10-15 | - | X-dag ordinarie utdelning CHEMM 4.00 DKK |
| 2021-10-14 | - | Årsstämma |
| 2021-09-16 | - | Bokslutskommuniké 2021 |
| 2021-02-05 | - | Kvartalsrapport 2021-Q2 |
| 2020-10-09 | - | X-dag ordinarie utdelning CHEMM 1.50 DKK |
| 2020-10-08 | - | Årsstämma |
| 2020-09-17 | - | Bokslutskommuniké 2020 |
| 2020-02-07 | - | Kvartalsrapport 2020-Q2 |
| 2020-01-14 | - | X-dag bonusutdelning CHEMM 13 |
| 2020-01-13 | - | Extra Bolagsstämma 2020 |
| 2019-10-11 | - | X-dag ordinarie utdelning CHEMM 7.50 DKK |
| 2019-10-10 | - | Årsstämma |
| 2019-09-17 | - | Bokslutskommuniké 2019 |
| 2019-02-08 | - | Kvartalsrapport 2019-Q2 |
| 2018-10-12 | - | X-dag ordinarie utdelning CHEMM 0.00 DKK |
| 2018-10-11 | - | Årsstämma |
| 2018-09-18 | - | Bokslutskommuniké 2018 |
| 2018-02-09 | - | Kvartalsrapport 2018-Q2 |
| 2017-11-15 | - | Årsstämma |
| 2017-10-13 | - | X-dag ordinarie utdelning CHEMM 0.00 DKK |
| 2017-10-12 | - | Årsstämma |
| 2017-09-19 | - | Bokslutskommuniké 2017 |
| 2017-02-10 | - | Kvartalsrapport 2017-Q2 |
| 2016-10-14 | - | X-dag ordinarie utdelning CHEMM 0.00 DKK |
| 2016-10-13 | - | Årsstämma |
| 2016-09-20 | - | Bokslutskommuniké 2016 |
| 2016-02-26 | - | Kvartalsrapport 2016-Q2 |
| 2015-10-09 | - | X-dag ordinarie utdelning CHEMM 0.00 DKK |
| 2015-10-08 | - | Årsstämma |
| 2015-05-15 | - | Kvartalsrapport 2015-Q3 |
| 2014-10-10 | - | X-dag ordinarie utdelning CHEMM 0.00 DKK |
| 2014-10-09 | - | Årsstämma |
| 2014-05-15 | - | Kvartalsrapport 2014-Q3 |
| 2013-11-15 | - | Kvartalsrapport 2014-Q1 |
| 2013-10-11 | - | X-dag ordinarie utdelning CHEMM 0.00 DKK |
| 2013-10-10 | - | Årsstämma |
| 2013-07-25 | - | Extra Bolagsstämma 2013 |
| 2013-05-14 | - | Kvartalsrapport 2013-Q3 |
| 2012-11-14 | - | Kvartalsrapport 2013-Q1 |
| 2012-10-12 | - | X-dag ordinarie utdelning CHEMM 0.00 DKK |
| 2012-10-11 | - | Årsstämma |
| 2012-05-11 | - | Kvartalsrapport 2012-Q3 |
| 2011-11-11 | - | Kvartalsrapport 2012-Q1 |
| 2011-10-14 | - | X-dag ordinarie utdelning CHEMM 0.00 DKK |
| 2011-10-13 | - | Årsstämma |
| 2011-05-13 | - | Kvartalsrapport 2011-Q3 |
| 2010-11-12 | - | Kvartalsrapport 2011-Q1 |
| 2010-10-06 | - | X-dag ordinarie utdelning CHEMM 0.00 DKK |
Beskrivning
| Land | Danmark |
|---|---|
| Lista | Large Cap Copenhagen |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
ANNOUNCEMENT NO. 270
2 July 2024
Preliminary revenue figures for the 2023/24 financial year
In the fourth quarter of the 2023/24 financial year, ChemoMetec's revenue was DKK 109.2 million, corresponding to a growth of 13.5% from the year-earlier period.
The revenue for the 2023/24 financial year was DKK 407.4 million against DKK 442.3 million the previous year, corresponding to a decrease of 7.9%. The revenue in 2023/24 is thus in line with the latest disclosed guidance for the revenue of DKK 400-415 million, disclosed on 8 May 2024.
In the fourth quarter of 2023/24, ChemoMetec sold XcytoMatic instruments for DKK 4.4 million, an increase of 69% compared to the third quarter of the financial year.
Revenue by product group
| DKKm | Q4 2023/24 | Q4 2022/23 | Q3 2023/24 | 2023/24 | 2022/23 |
| Instruments | 32.2 | 32.0 | 23.1 | 117.1 | 179.0 |
| Consumables | 50.4 | 41.8 | 52.6 | 192.5 | 174.4 |
| Services | 25.4 | 21.4 | 22.1 | 93.5 | 83.0 |
| Other | 1.2 | 1.0 | 1.1 | 4.3 | 5.9 |
| Total revenue | 109.2 | 96.2 | 98.9 | 407.4 | 442.3 |
In the annual report for 2023/24, which will be published on 11 September 2024, the development in revenue will be further described.
The previously announced guidance for EBITDA in 2023/24 (DKK 185-200 million) is maintained.
For further information
CEO Martin Helbo Behrens
Phone: (+45) 4813 1020
About ChemoMetec A/S
ChemoMetec develops, manufactures and markets instruments for cell counting and a wide range of other measurements. ChemoMetec’s instruments are marketed to the pharmaceutical, biotech and agricultural industries worldwide. ChemoMetec’s customers include some of the world’s leading pharmaceutical companies.
ChemoMetec was founded in 1997 and is listed on the Nasdaq Copenhagen stock exchange. For more information, go to www.chemometec.com